Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.80 |
| ▸ | CNR2 | P34972 | 3/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.80 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38658046 | 1.00 | CNR1 (0.80) | CNR1CNR2ALDH1A1FAAHMAPT | |
| SCHEMBL1077755 | 1.00 | CNR1 (0.80) | CNR1CNR2ALDH1A1FAAHMAPT | |
| SCHEMBL18686822 | 1.00 | CNR1 (0.80) | CNR1CNR2ALDH1A1FAAHMAPT | |
| SCHEMBL9754773 | 1.00 | CNR1 (0.80) | CNR1CNR2ALDH1A1FAAHMAPT | |
| SCHEMBL9754767 | 1.00 | CNR1 (0.80) | CNR1CNR2ALDH1A1FAAHMAPT | |
| SCHEMBL3491386 | 1.00 | CNR1 (0.80) | CNR1CNR2ALDH1A1FAAHMAPT | |
| SCHEMBL2228956 | 0.98 | CNR1 (0.82) | CNR1CNR2ALDH1A1FAAHMAPT | |
| SCHEMBL2228952 | 0.98 | CNR1 (0.82) | CNR1CNR2ALDH1A1FAAHMAPT | |
| SCHEMBL24208055 | 0.95 | CNR1 (0.71) | CNR1CNR2ALDH1A1 | |
| SCHEMBL10492037 | 0.95 | CNR1 (0.71) | CNR1CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3825397-B1 | METHOD FOR PRODUCING PARASYMPATHETIC NEURONS | AIST (JP) | 2023-04-19 | — | — | EP | claimed |
| EP-4424819-A1 | METHOD FOR PRODUCING MYOCARDIAL CELL LAYER, MYOCARDIAL CELL LAYER, AND USE THEREOF | FUJIFILM Corporation (JP) | 2024-09-04 | — | — | EP | disclosed |
| US-20240277899-A1 | PRODUCTION METHOD OF MYOCARDIAL CELL LAYER, MYOCARDIAL CELL LAYER, AND USE THEREOF | FUJIFILM CORPORATION (JP) | 2024-08-22 | — | — | US | disclosed |
| WO-2023074783-A1 | METHOD FOR PRODUCING MYOCARDIAL CELL LAYER, MYOCARDIAL CELL LAYER, AND USE THEREOF | 富士フイルム株式会社 | 2023-05-04 | — | — | WO | disclosed |
| EP-3825397-B1 | METHOD FOR PRODUCING PARASYMPATHETIC NEURONS | AIST (JP) | 2023-04-19 | — | — | EP | disclosed |
| WO-2023033128-A1 | METHOD FOR PRODUCING PROTEIN | 国立大学法人京都大学 | 2023-03-09 | — | — | WO | disclosed |
| US-11359178-B2 | Method for producing parasympathetic neurons | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2022-06-14 | — | — | US | disclosed |
| US-20210171905-A1 | METHOD FOR PRODUCING PARASYMPATHETIC NEURONS | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2021-06-10 | — | — | US | disclosed |
| EP-3825397-A1 | PRODUCTION METHOD FOR PARASYMPATHETIC NERVE CELLS | National Institute of Advanced Industrial Science and Technology (JP) | 2021-05-26 | — | — | EP | disclosed |
| WO-2020040286-A1 | PRODUCTION METHOD FOR PARASYMPATHETIC NERVE CELLS | 国立研究開発法人産業技術総合研究所 | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240277899-A1 | PRODUCTION METHOD OF MYOCARDIAL CELL LAYER, MYOCARDIAL CELL LAYER, AND USE THEREOF | KIT, MYLK2, TNNT2 | CNR1 2662/4885CNR2 2612/4885ALDH1A1 671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.